Investors Sue Pharma Co. In Chancery Over Diabetes Drug
A shareholder of Provention Bio Inc. filed a derivative suit against the company's officers and directors in Delaware's Chancery Court for damages surrounding the alleged hype of a type 1 diabetes...To view the full article, register now.
Already a subscriber? Click here to view full article